AAMDSIF Upcoming Webinars: August 2019

The Aplastic Anemia and MDS International Foundation presents webinars for patients and their loved ones at no charge to participants. 
BY AAMDSIF
PUBLISHED July 22, 2019
The Aplastic Anemia and MDS International Foundation presents webinars for patients and their loved ones at no charge to participants.  All webinars are recorded and posted one week past the event for anyone to view on-demand.

On August 7th, 2019,  at 3:00pm EDT, the webinar is "Relapsed CLL - Why and How to Treat." 



In this webinar, Dr. Jonathon Cohen from Winship Cancer Institute of Emory University will discuss relapsed CLL- what causes patients to relapse and how to treat relapsed disease. Participants will have the opportunity to ask Dr. Cohen questions. 

AAMDSIF encourages everyone who is considering watching this webinar in real-time or on demand to register today at this link: https://www.pathlms.com/aamdsif/webinars/5241.

For questions or concerns, please send your email to Leigh at clark@aamds.org. 
https://www.aamds.org/education/courses
 
 
The Aplastic Anemia and MDS International Foundation presents webinars for patients and their loved ones at no charge to participants.  All webinars are recorded and posted one week past the event for anyone to view on-demand.

On August 21st, 2019, at 3:00 pm EDT, we are presenting: “Low Risk vs High Risk MDS - what's the difference?”



Dr. Marlise Luskin from Dana Farber Cancer Institute. She will define high-risk MDS versus low-risk MDS, impact for patients and what treatment options are available.

This webinar is brought to you by the generous support of Celgene and Jazz Pharmaceuticals.

AAMDSIF encourages everyone who is considering watching this webinar in real-time or on demand to register today at this link: https://www.pathlms.com/aamdsif/webinars/5237.

For questions or concerns, please send your email to Leigh at clark@aamds.org. 
https://www.aamds.org/education/courses
 

The Aplastic Anemia and MDS International Foundation presents webinars for patients and their loved ones at no charge to participants.  All webinars are recorded and posted one week past the event for anyone to view on-demand.

On August 22nd, 2019 at 4:00 PM EDT, we will present: “Refractory/Relapsed AML - Why and How to Treat?”



In this webinar, Dr. Elie Traer from OHSU Knight Cancer Institute in Portland, OR will discuss what is refractory/relapsed AML, how it is diagnosed, affects on treatments and what this diagnosis means for patients. Participants will have the opportunity to ask Dr. Traer their questions.

This webinar is brought to you by the generous support of Agios, Celgene and Jazz Pharmaceuticals.

AAMDSIF encourages everyone who is considering watching this webinar in real-time or on demand to register today at this link: https://www.pathlms.com/aamdsif/webinars/4113.

For questions or concerns, please send your email to Leigh at clark@aamds.org. 
https://www.aamds.org/education/courses
 
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the MDS CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In